Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
NYSE:JNJ
JNJ Stock Chart & Stats
$189.05
-$4.08(-2.79%)
At close: 4:00 PM EST
$189.05
-$4.08(-2.79%)
Day’s Range― - ―
52-Week Range$140.68 - $194.48
Previous CloseN/A
Volume3.80M
Average Volume (3M)8.95M
Market Cap
$455.48B
Enterprise Value$463.68B
Total Cash (Recent Filing)$18.56B
Total Debt (Recent Filing)$6.39B
Price to Earnings (P/E)18.0
Beta0.17
Next Earnings
Jan 21, 2026EPS Estimate
2.54Next Dividend Ex-Date
Nov 25, 2025Dividend Yield2.69%
Share Statistics
EPS (TTM)2.80
Shares Outstanding2,409,295,200
10 Day Avg. Volume8,005,669
30 Day Avg. Volume8,952,237
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)4.83
Price to Sales (P/S)3.88
P/FCF Ratio17.39
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue6.66
Enterprise Value/Gross Profit9.79
Enterprise Value/Ebitda13.78
Forecast
1Y Price Target
$206.47Price Target Upside9.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
Bulls Say, Bears Say
Bulls Say
Business StrategyPlans to spin out the orthopedic side of MedTech should benefit from improved focus and become more competitive.
Financial PerformanceStrong performance likely reflects JNJ being perceived as a comparatively safe and defensive name relative to other large biopharma peers, but also decent financial performance.
R&D InvestmentThe company reiterated its $55 billion manufacturing and R&D commitment over the next four years, enabling advanced medicines to be made domestically.
Bears Say
Growth ExpectationsAnalysts maintain a Neutral rating due to about-average growth despite decent financial performance year-to-date.
Tax Rate ImpactJNJ now expects a higher tax rate of 17.5%-18.0% due to the OBBBA.
Valuation ConcernsThe company's valuation is considered above-average, even when factoring in the higher multiple for the MedTech business, implying it is fairly valued.
Johnson & Johnson News
JNJ FAQ
What was Johnson & Johnson’s price range in the past 12 months?
Johnson & Johnson lowest stock price was $140.68 and its highest was $194.48 in the past 12 months.
What is Johnson & Johnson’s market cap?
Johnson & Johnson’s market cap is $455.48B.
When is Johnson & Johnson’s upcoming earnings report date?
Johnson & Johnson’s upcoming earnings report date is Jan 21, 2026 which is in 82 days.
How were Johnson & Johnson’s earnings last quarter?
Johnson & Johnson released its earnings results on Oct 14, 2025. The company reported $2.8 earnings per share for the quarter, beating the consensus estimate of $2.757 by $0.043.
Is Johnson & Johnson overvalued?
According to Wall Street analysts Johnson & Johnson’s price is currently Undervalued.
Does Johnson & Johnson pay dividends?
Johnson & Johnson pays a Quarterly dividend of $1.3 which represents an annual dividend yield of 2.69%. See more information on Johnson & Johnson dividends here
What is Johnson & Johnson’s EPS estimate?
Johnson & Johnson’s EPS estimate is 2.54.
How many shares outstanding does Johnson & Johnson have?
Johnson & Johnson has 2,409,295,200 shares outstanding.
What happened to Johnson & Johnson’s price movement after its last earnings report?
Johnson & Johnson reported an EPS of $2.8 in its last earnings report, beating expectations of $2.757. Following the earnings report the stock price went down -0.026%.
Which hedge fund is a major shareholder of Johnson & Johnson?
Currently, no hedge funds are holding shares in JNJ
Johnson & Johnson Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$206.47 (9.21% Upside)
$206.47 (9.21% Upside)
Blogger Sentiment
Bullish
JNJ Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 704.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $39.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.32%
12-Months-Change
Fundamentals
Return on Equity
33.62%
Trailing 12-Months
Asset Growth
8.15%
Trailing 12-Months
Company Description
Johnson & Johnson
Johnson & Johnson (JNJ) is a multinational corporation founded in 1886, known for its diverse range of healthcare products and services. The company operates through three main sectors: Consumer Health, Pharmaceutical, and Medical Devices. Its portfolio includes well-known consumer products such as baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals. In the pharmaceutical sector, JNJ develops innovative treatments across various therapeutic areas, including immunology, oncology, neuroscience, and infectious diseases. The Medical Devices segment offers a wide array of products used in surgical, orthopedic, and interventional procedures, making JNJ a key player in the global healthcare market.
JNJ Company Deck
JNJ Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Johnson & Johnson demonstrated strong overall performance with significant growth across key segments and successful new product launches. Despite challenges from STELARA's loss of exclusivity and increased tax rates, the company's strategic focus and operational achievements suggest a positive outlook.View all JNJ earnings summariesJNJ Sales Breakdown
64.13% Innovative Medicine
35.87% MedTech
JNJ Stock 12 Month Forecast
Average Price Target
$206.47
▲(9.21% Upside)
Technical Analysis
Ownership Overview
0.04% Insiders
18.49% Mutual Funds
0.53% Other Institutional Investors
58.77% Public Companies and Individual Investors